Abstract
In a pilot randomized trial in persons with opioid use disorder hospitalized with injection-related infections, an innovative care model combining outpatient parenteral antimicrobial therapy with buprenorphine treatment had similar clinical and drug use outcomes to usual care (inpatient intravenous antibiotic completion) and shortened hospital length of stay by 23.5 days. Clinical Trials Registration: NCT03048643.
Original language | English |
---|---|
Pages (from-to) | 1226-1229 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 70 |
Issue number | 6 |
DOIs | |
State | Published - Mar 3 2020 |
Bibliographical note
Publisher Copyright:© 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Keywords
- antibiotics
- buprenorphine
- endocarditis
- injection-drug use
- opioid-related disorders
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases